Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(17 sites)

United States

John Muir Medical Center, Concord, California

Ascension Via Christi Hospitals Wichita, Wichita, Kansas

North Shore University Hospital, Manhasset, New York

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, New York

Baylor Scott & White The Heart Hospital - Dallas, Dallas, Texas

Ascension Texas Cardiovascular, Kyle, Texas

Charleston Area Medical Center, Charleston, West Virginia

Austria

Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien, Vienna, State of Vienna

Klinische Abteilung für Kardiologie, Medizinische Universität Graz, Graz, Styria

France

Institut Arnault Tzanck, Saint-Laurent-du-Var, Provence-Alpes-Côte d'Azur Region

Germany

Universitätsklinikum Mannheim, I. Medizinische Klinik, Mannheim, Baden-Wurttemberg

Klinikum Fürth, Fürth, Bavaria

Universitätsklinikum Würzburg, Würzburg, Bavaria

Segeberger Kliniken GmbH, Bad Segeberg, Schleswig-Holstein

Poland

Miedziowe Centrum Zdrowia SA, Lubin, Lower Silesian Voivodeship

Switzerland

University hospital Basel, Basel, Canton of Basel-City

Istituto Cardiocentro Ticino, Lugano, Canton Ticino